The Viral Vectors and Plasmid DNA Manufacturing Market is expected to experience sustained momentum as gene-based therapies transition from clinical trials to commercial-scale production. Governments and healthcare institutions are increasing funding for advanced therapeutics, particularly in rare genetic disorders and cancer treatment. This growing support is accelerating demand for...